Perbak Capital Partners »

Catalyst Pharmaceutical Partners shares owned by Perbak Capital Partners

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Perbak Capital Partners from 13F filings

Historical chart of Perbak Capital Partners investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Perbak Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Perbak Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $256k 10k 24.76

More positions owned by Perbak Capital Partners

Select Sector Spdr Tr State Street Ind (XLI)
Select Sector Spdr Tr State Street Con (XLY)
Select Sector Spdr Tr State Street Con (XLP)
Vaneck Etf Trust Oil Services Etf (OIH)
Spdr Series Trust State Street Spd (KIE)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Real Estate Etf (VNQ)
Select Sector Spdr Tr State Street Mat (XLB)
Select Sector Spdr Tr State Street Hea (XLV)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
Ishares Tr Ishares Semicdtr (SOXX)
Draftkings Com Cl A (DKNG)
Spdr Series Trust State Street Spd (XHB)
Northrop Grumman Corporation (NOC)

View all positions for Perbak Capital Partners

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
Vanguard Capital Management
American Century Companies
Deerfield Management Company
Dimensional Fund Advisors
Bank of America Corporation
Geode Capital Management
Morgan Stanley
Vanguard Portfolio Management
Renaissance Technologies
Royce & Associates
Henderson Group
Robeco Investment Management
Charles Schwab Investment Management

View all funds holding Catalyst Pharmaceutical Partners